HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fiona Blackhall Selected Research

Fiona Blackhall Research Topics

Disease

51Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 06/2005
40Neoplasms (Cancer)
01/2023 - 04/2007
31Lung Neoplasms (Lung Cancer)
10/2023 - 08/2004
28Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2024 - 01/2010
12Disease Progression
01/2023 - 06/2012
8Neoplasm Metastasis (Metastasis)
10/2023 - 11/2011
6Fatigue
01/2023 - 06/2013
6Circulating Neoplastic Cells
01/2020 - 10/2013
4Dyspnea (Shortness of Breath)
10/2022 - 06/2013
3Nausea
10/2022 - 12/2014
3Cough
01/2021 - 11/2014
3Hypoxia (Hypoxemia)
01/2018 - 03/2011
3Epilepsy (Aura)
10/2017 - 04/2017
3Thrombocytopenia (Thrombopenia)
09/2017 - 10/2011
3Neutropenia
01/2017 - 08/2015
2Melanoma (Melanoma, Malignant)
01/2023 - 08/2016
2Pain (Aches)
01/2023 - 11/2014
2Hemoptysis
01/2023 - 08/2014
2Edema (Dropsy)
01/2021 - 12/2014
2Vomiting
01/2021 - 12/2014
2Febrile Neutropenia
09/2017 - 10/2011
2Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 03/2011
2Diarrhea
12/2014 - 11/2014
2Vision Disorders (Hemeralopia)
12/2014 - 06/2013
2Adenocarcinoma
08/2012 - 06/2010
1Adenocarcinoma of Lung
10/2023
1Neuroendocrine Carcinoma
01/2023
1Kidney Neoplasms (Kidney Cancer)
01/2023
1Ovarian Neoplasms (Ovarian Cancer)
10/2022
1Hyponatremia
10/2021
1Thoracic Diseases
01/2019
1Myositis (Idiopathic Inflammatory Myopathies)
01/2018

Drug/Important Bio-Agent (IBA)

15Biomarkers (Surrogate Marker)IBA
01/2023 - 08/2008
10PlatinumIBA
10/2022 - 07/2005
8ErbB Receptors (EGF Receptor)IBA
07/2018 - 01/2005
8Carboplatin (JM8)FDA LinkGeneric
09/2017 - 12/2007
7CrizotinibIBA
01/2018 - 02/2013
6Tyrosine Kinase InhibitorsIBA
09/2021 - 01/2005
6Paclitaxel (Taxol)FDA LinkGeneric
08/2014 - 12/2007
5Docetaxel (Taxotere)FDA Link
01/2017 - 12/2007
4Proteins (Proteins, Gene)FDA Link
10/2023 - 03/2011
4osimertinibIBA
07/2018 - 04/2017
4Anaplastic Lymphoma KinaseIBA
01/2018 - 02/2013
4Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2017 - 06/2005
4Gefitinib (Iressa)FDA Link
02/2013 - 01/2005
3LigandsIBA
11/2023 - 01/2021
3DNA (Deoxyribonucleic Acid)IBA
10/2022 - 01/2017
3GemcitabineFDA Link
09/2017 - 12/2007
3Pemetrexed (MTA)FDA Link
09/2017 - 07/2014
3Cisplatin (Platino)FDA LinkGeneric
09/2017 - 04/2011
3AZD 6244IBA
09/2017 - 11/2016
2Cadherins (E-Cadherin)IBA
10/2023 - 03/2011
2pembrolizumabIBA
01/2023 - 01/2022
2olaparibIBA
10/2022 - 10/2018
2Cell-Free Nucleic AcidsIBA
10/2022 - 01/2020
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2022 - 10/2018
2Etoposide (VP 16)FDA LinkGeneric
11/2021 - 04/2011
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021 - 10/2011
2Antitussive Agents (Antitussives)FDA Link
01/2021 - 04/2017
2Immune Checkpoint InhibitorsIBA
01/2020 - 07/2018
2EpitopesIBA
01/2020 - 01/2016
2MicroRNAs (MicroRNA)IBA
02/2016 - 12/2013
2ABT-737IBA
01/2016 - 03/2011
2motesanib diphosphateIBA
08/2014 - 08/2012
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2014 - 08/2012
2human TNFSF10 proteinIBA
11/2011 - 03/2010
2Bevacizumab (Avastin)FDA Link
11/2011 - 03/2010
1Transcription Factors (Transcription Factor)IBA
02/2024
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
10/2023
1ProtocadherinsIBA
10/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1Immunoconjugates (Immunoconjugate)IBA
01/2023
1AMG 757IBA
01/2023
1SmokeIBA
12/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2022
1Soluble Guanylyl CyclaseIBA
11/2021
1Monomeric GTP-Binding ProteinsIBA
11/2021
1TolvaptanFDA Link
10/2021
1erythromycin propionate-N-acetylcysteinateIBA
04/2021
1Topotecan (Hycamtin)FDA LinkGeneric
01/2021
1Substance PIBA
01/2021
1Aprepitant (Emend)FDA Link
01/2021
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2021
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1Phosphotransferases (Kinase)IBA
10/2018
1adavosertibIBA
10/2018
1Circulating Tumor DNAIBA
07/2018
1methylamphotericin B (AME)IBA
07/2018
1Ligases (Synthetase)IBA
01/2018
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2018
1transcriptional intermediary factor 1IBA
01/2018
1nuclear matrix protein 2IBA
01/2018

Therapy/Procedure

36Drug Therapy (Chemotherapy)
06/2023 - 01/2005
32Therapeutics
01/2023 - 06/2005
19Radiotherapy
06/2023 - 01/2005
6Immunotherapy
11/2023 - 08/2016
6Chemoradiotherapy
01/2019 - 07/2005
2Aftercare (After-Treatment)
10/2017 - 12/2013
1Cranial Irradiation
01/2019